AM 1476
Alternative Names: AM-1476Latest Information Update: 16 Feb 2024
At a glance
- Originator AnaMar AB
- Class Amines; Antifibrotics; Benzylidene compounds; Guanidines; Skin disorder therapies; Small molecules
- Mechanism of Action Serotonin 2B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I Systemic scleroderma